Nanomotor-based H(2)S donor with mitochondrial targeting function for treatment of Parkinson's disease

Reduction of endogenous hydrogen sulfide (H(2)S) is considered to have an important impact on the progress of Parkinson's disease (PD), thus exogenous H(2)S supplementation is expected to become one of the key means to treat PD. However, at present, it is difficult for H(2)S donors to effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zinan, Chen, Lin, Yang, Chunhao, Guo, Wenyan, Huang, Yali, Wang, Wenjing, Wan, Mimi, Mao, Chun, Shen, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522957/
https://www.ncbi.nlm.nih.gov/pubmed/37771932
http://dx.doi.org/10.1016/j.bioactmat.2023.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522957/
https://www.ncbi.nlm.nih.gov/pubmed/37771932
http://dx.doi.org/10.1016/j.bioactmat.2023.09.001

Ejemplares similares